Internal Medicine, Pulmonary Disease · Austin, TX
NPI
1477712891
Since 2008
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
1301 W 38th St Ste 514
Austin, TX, 78705
Phone (512) 681-0500
Groups this clinician bills Medicare through
Medicare paid, 2024
$17K
164 services
Medicare patients, 2024
75
Average age 71
Drug cost, 2024
$2.1M
349 prescriptions
Company payments, 2025
$123
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anna K Dvorak was code 99291 (critical care e&m), 53 times for 25 patients. In total Anna K Dvorak billed 164 services in 18 codes, and Medicare paid $17K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-05-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99291 Critical Care E&M | Facility | 53 | 25 | $165.33 | $8,763 |
| 99214 Office E&M - Established | Facility | 32 | 15 | $71.51 | $2,288 |
| 99233 Hospital E&M - Subsequent | Facility | 23 | 19 | $92.55 | $2,129 |
| 99232 Hospital E&M - Subsequent | Facility | 18 | 12 | $61.62 | $1,109 |
By year: 2022 $23K for 246 services; 2023 $23K for 224 services; 2024 $17K for 164 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anna K Dvorak prescribed most often to Medicare patients was Tadalafil, with 66 prescriptions and refills. In total Anna K Dvorak wrote 349 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tadalafil Generic | 66 | 67 | Under 11 | $50K |
| Opsumit Macitentan | 65 | 65 | Under 11 | $814K |
| Remodulin Treprostinil Sodium | 53 | 53 | Under 11 | $290K |
| Potassium Chloride Generic | 34 | 59 | Under 11 | $408 |
| Uptravi Selexipag | 24 | 24 | Under 11 | $638K |
| Ambrisentan Generic | 21 | 21 | Under 11 | $94K |
| Furosemide Generic | 14 | 24 | Under 11 | $60.48 |
| Sildenafil Citrate Generic | 14 | 14 | Under 11 | $653 |
Brand drugs: 172 claims; generic drugs: 177 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anna K Dvorak $123 ($123 in general payments such as food, travel and fees) from 1 company. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $123.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $123 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.